A Journey from Protein to Compound: Virtual Screening at MDC

Kepa Burusco-Goni, Mouhamad Aboshokor, and Gemma L. Holliday

ELRIG Poster A Journey from Protein to Compound: Virtual Screening at Medicines Discovery Catapult. What other proteins could be druggable?

A Journey from Protein to Compound: Virtual Screening at MDC:

Lately, there has been an explosion of data in the public domain relating to the human genome. Such explosion comes from the sequencing of the so-called Dark Genome, a more in-depth analysis of the genome-disease association, large-scale sequencing efforts of Genomics England (and beyond), and biobanks across the world. All over the world, experts are asking the question: what other proteins could be druggable? How do we best use the data and techniques available to explore beyond the traditional? How can we repurpose existing compounds to find novel applications? A Journey from Protein to Compound: Virtual Screening at MDC

This poster was created for ELRIG Drug Discovery 2022.

 

ELRIG Poster A Journey from Protein to Compound: Virtual Screening at Medicines Discovery Catapult. What other proteins could be druggable?